Access to prescription medicines and therapies affects all Canadians due to the barriers of cost and availability in the healthcare system. Too often, we find patients choosing whether to pay for their prescription medicines or basic necessities such as food. In some cases, patients die or their quality of life significantly deteriorates waiting for their drugs to be approved by multiple drug approval agencies. “Canada
The Advisory Council on the Implementation of National Pharmacare is inviting Canadians to share their ideas and views about national pharmacare. As part of the National Pharmacare Online Consultation, there is a new questionnaire available that is open to all Canadians to share their thoughts on national pharmacare. The input gathered will help inform the Council’s advice to the Government on how to best implement
NATIONAL PHARMACARE WEBINAR DEBATES Presented by the Canadian Association for Rare Disorders (CORD) The biggest changes in over 30 years to drug regulations and drug plans in Canada will be implemented over the next year. Will your access to prescription drugs get better … or worse? Will the Ontario Conservative government’s rollback on OHIP+ (excluding kids with private drug coverage) affect a proposed National Pharmacare program? It’s
We are surveying all Canadians to understand what cancer survivorship means to them, and we are asking you to complete the survey so we understand what it means to you. Click here to take the survey. We ask that you complete the survey by Friday, July 27th. We will use these findings to raise awareness and to inform conversations with government and other healthcare organizations.
Originally broadcast July 5th, 2018 We welcomed Dr. Andrew Feifer for a presentation about Ned, an app designed specifically for prostate cancer patients, as well as a discussion about the incorporation of data driven smart technology in the survivorship of cancer patients. The webinar was followed by an interactive question & answer session. Ned was conceptualized and co-founded by our webinar presenter: Dr. Andrew Feifer,
As the debate about pharmacare in Canada heats up with the Implementation of the Advisory Council on Pharmacare, and the role this plays in the coming federal election in 2019, various pieces that misrepresent the case for pharmacare are appearing. While consumers and healthcare advocates need to gain knowledge about the issues surrounding pharmacare, they also need to be cautious of inaccurate titles and claims,